SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 112.49 |
Enterprise Value ($M) | 128.57 |
Book Value ($M) | 51.35 |
Book Value / Share | 0.39 |
Price / Book | 2.19 |
NCAV ($M) | 23.61 |
NCAV / Share | 0.18 |
Price / NCAV | 4.77 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.01 |
Return on Assets (ROA) | 0.01 |
Return on Equity (ROE) | 0.02 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.22 |
Current Ratio | 2.82 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 64.87 |
Assets | 92.61 |
Liabilities | 41.26 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 91.30 |
Operating Income | -10.16 |
Net Income | 0.66 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -9.52 |
Cash from Investing | -24.78 |
Cash from Financing | 19.69 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Altium Capital Management LP | 6.20 | 28.52 | |
13D/A | Orbimed Advisors Llc | 56.70 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
27,558 | 273,702 | 10.07 | |
3,992 | 67,343 | 5.93 | |
12,056 | 27,509 | 43.83 | |
10,142 | 36,184 | 28.03 | |
1,166 | 53,497 | 2.18 | |
(click for more detail) |
Similar Companies | |
---|---|
TOVX – Theriva Biologics, Inc. | VCXB – 10X Capital Venture Acquisition Corp. III |
VNRX – VolitionRx Limited |